Cover Image

The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil

Abstract: The public production of medicines in Brazil by Government Pharmaceutical Laboratories has once again become the object of incentives, and Industrial Development Partnerships are one of the mechanisms adopted for the production of strategic medicines for the Brazilian Unified National Heal...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tatiana Aragão Figueiredo (Author), Joyce Mendes de Andrade Schramm (Author), Vera Lúcia Edais Pepe (Author)
Format:	Book
Published:	Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2017-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil
by: Tatiana Aragão Figueiredo, et al.
Published: (2013)

Seleção de medicamentos essenciais e a carga de doença no Brasil
by: Tatiana Aragão Figueiredo, et al.
Published: (2014)

O mercado brasileiro de anticorpos monoclonais utilizados para o tratamento de câncer
by: Thaís Jeronimo Vidal, et al.
Published: (2018)

Racionalidade terapêutica: elementos médico-sanitários nas demandas judiciais de medicamentos Racionalidad terapéutica: elementos medico-sanitarios en las demandas judiciales de medicamento Rational therapeutics: health-related elements in lawsuits demanding medicines
by: João Mauricio Brambati Sant'Ana, et al.
Published: (2011)

Caracterização de demandas judiciais de fornecimento de medicamentos "essenciais" no Estado do Rio de Janeiro, Brasil Characterization of lawsuits for the supply of "essential" medicines in the State of Rio de Janeiro, Brazil
by: Vera Lúcia Edais Pepe, et al.
Published: (2010)

"Ao persistirem os sintomas, o médico deverá ser consultado": isto é regulação?
by: Vera Lucia Edais Pepe
Published: (2006)

"Ao persistirem os sintomas, o médico deverá ser consultado": isto é regulação?
by: Vera Lucia Edais Pepe

Diabetes burden in Brazil: fraction attributable to overweight, obesity, and excess weight
by: Luísa Sorio Flor, et al.
Published: (2015)

A definição de medicamentos prioritários para o monitoramento da qualidade laboratorial no Brasil: articulação entre a vigilância sanitária e a Política Nacional de Medicamentos Definition of priority medicines for monitoring laboratory quality in Brazil: the interface between health surveillance and the National Drug Policy
by: Durval Martins Pontes Junior, et al.
Published: (2008)

Sources of medicines for hypertension and diabetes in Brazil: results from the National Health Survey
by: Sotero Serrate Mengue, et al.
Published: (2022)

Public policy coverage and access to medicines in Brazil
by: Ricardo Montes de Moraes, et al.
Published: (2022)

Use of medicines and other products for therapeutic purposes among children in Brazil
by: Tatiane da Silva Dal Pizzol, et al.

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS
by: Margareth Crisóstomo Portela, et al.

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS
by: Portela Margareth Crisóstomo, et al.
Published: (1997)

Algoritmo para a composição de dados por internação a partir do sistema de informações hospitalares do sistema único de saúde (SIH/SUS) - Composição de dados por internação a partir do SIH/SUS Algorithm for establishing hospital admittance data based on the hospital information system in the Brazilian Unified Health System (SIH/SUS)
by: Margareth Crisóstomo Portela, et al.
Published: (1997)

Racionalidade terapêutica: elementos médico-sanitários nas demandas judiciais de medicamentos
by: João Mauricio Brambati Sant'Ana, et al.

Critérios e indicadores de resultados para a farmácia hospitalar brasileira utilizando o método Delfos Establishment of criteria and outcome indicators for hospital pharmacies in Brazil using Delphos
by: Rachel Magarinos-Torres, et al.
Published: (2007)

Pharmaceutical policies for gaining access to high-priced medicines: a comparative analysis between England and Brazil
by: Geison Vicente, et al.
Published: (2022)

The role of health policy in the burden of breast cancer in Brazil
by: Francisco Winter dos Santos Figueiredo, et al.
Published: (2017)

Morbidity and mortality associated with injuries: results of the Global Burden of Disease study in Brazil, 2008
by: Mônica Rodrigues Campos, et al.
Published: (2015)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
by: Ayo-Oley Baldeh, et al.
Published: (2023)

Complexity of Medicine Regimens and Patient Perception of Medicine Burden
by: Janet Krska, et al.
Published: (2019)

Catastrophic expenditure on medicines in Brazil
by: Vera Lucia Luiza, et al.

Sistema Nacional de Farmacovigilância no Brasil e em Portugal: semelhanças, diferenças e desafios
by: Vera Lúcia Edais Pepe, et al.
Published: (2020)

Novos delineamentos da Assistência Farmacêutica frente à regulamentação da Lei Orgânica da Saúde Nuevos planteamientos de asistencia farmacéutica frente a la regulación de la Ley Orgánica de Salud Essential medicines and technology incorporation following novel Brazilian Public Health System regulations
by: Vera Lúcia Edais Pepe, et al.
Published: (2013)

First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
by: Ranailla Lima Bandeira dos Santos, et al.
Published: (2023)

Strengthening access to cancer medicines for children in East Africa: policy options to enhance medicine procurement, forecasting, and regulations
by: Kadia Petricca, et al.
Published: (2024)

Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators
by: Katrina Perehudoff
Published: (2020)

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico
by: Pepe Vera Lúcia Edais, et al.
Published: (2000)

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico
by: Vera Lúcia Edais Pepe, et al.

A interação entre prescritores, dispensadores e pacientes: informação compartilhada como possível benefício terapêutico Interaction between prescribers, dispensers, and patients: shared information as a possible therapeutic benefit
by: Vera Lúcia Edais Pepe, et al.
Published: (2000)

National policy for integration of ICT: a comparative study between Brazil and Spain
by: José GOMES DA SILVA, et al.
Published: (2018)

Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine
by: Jhi Biau Foo, et al.
Published: (2021)

Nitrosamines in medicinal products
by: Katarzyna Dominiak, et al.
Published: (2022)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

A produção pública de medicamentos no Brasil: uma visão geral Public production of medicines in Brazil: an overview
by: Egléubia Andrade de Oliveira, et al.
Published: (2006)

Animals and their products utilized as medicines by the inhabitants surrounding the Ranthambhore National Park, India
by: Jaroli DP, et al.
Published: (2006)

The Effect of China's National Essential Medicine Policy on Health Expenses: Evidence From a National Study
by: Qian Li PhD, et al.
Published: (2018)

The 21st Century Cures Act: can the regulatory framework survive the "cures"?
by: Claudia Garcia Serpa Osorio-, et al.
Published: (2015)

Comparative price analysis of biological medicines: disparities generated by different pricing policies
by: Marcela Amaral Pontes, et al.
Published: (2024)